Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain

• Main Authors: Galve-Calvo E (Author), González-Haba E (Author), Gostkorzewicz J (Author), Martínez I (Author), Pérez-Mitru A (Author)
• Format: Book
• Published: Dove Medical Press, 2018-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Elena Galve-Calvo,1 Eva González-Haba,2 Joana Gostkorzewicz,3 Irene Martínez,4 Alejandro Pérez-Mitru4 1Medical Oncology Service, Basurto University Hospital, Bilbao, Spain; 2Pharmacy Department, Hospital Universitario Gregorio Marañón, Madrid, Spain; 3Novartis Farmacéutica, S.A., Health Economics an...